Citations

Citations to this article as recorded by  

• Overcoming resistance: targeted nanomedicine solutions for cancer therapy
  Bhaveshkumar Patel, Ankur Vashi, Akhilesh Kumar Kuril, Praveen Kumar Subbappa, Ramakrishna Borra
  Journal of Biomaterials Science, Polymer Edition.2026; 37(6): 1193.     CrossRef
• Innovations in targeted drug delivery: From nanotechnology to clinical applications
  Akash Srivastava, Asad Ahmad, Shaiber Siddiqui, Anas Islam
  Next Nanotechnology.2026; 9: 100336.     CrossRef
• Regulatory framework for polymer-based nanotherapeutics in clinical translation
  Federico Stucchi, Min Li, Giuseppe Castellano, Francesco Cellesi
  Frontiers in Bioengineering and Biotechnology.2026;[Epub]     CrossRef
• Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems
  Rayna Georgieva Bryaskova, Krasimir Georgiev Staykov, Damyan Stoyanov Ganchev
  Pharmaceutics.2026; 18(2): 177.     CrossRef
• The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid Tumors
  Vaibhav Choudhary, Nirmal Raut, Gajanan Panchal, Maneesha Khalse, Kamlesh Patel
  Indian Journal of Medical and Paediatric Oncology.2026;[Epub]     CrossRef
• Clinical advances and challenges of antibody-mediated targeted drug delivery in breast cancer therapeutics
  Mokhtar Rejili
  Discover Oncology.2026;[Epub]     CrossRef
• Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations
  Jihoon Lee, Min-Koo Choi, Im-Sook Song
  Archives of Pharmacal Research.2026; 49(4): 500.     CrossRef
• Personalized Nanomedicine: Integrating Molecular Stratification with Engineered Delivery Systems
  Segev Sharon, Gayatri Mainkar, Lior Zangi
  Journal of Nanotheranostics.2026; 7(2): 9.     CrossRef
• In vitro Anticancer Activity of Flaxseed Oil Loaded-Polymeric Micelles in Breast Cancer Cell Line
  Eda Nur Yetiskin Morkan, Maria Daaboul, Shifa Alhamvi, Gulsah Akbas, Banu Mansuroglu, Murat Topuzogullari
  Brazilian Archives of Biology and Technology.2026;[Epub]     CrossRef
• Disrupting the metastatic cascade: nanoparticle-based innovations in antimetastatic therapy
  Tamara Meňhertová, Martina Raudenská, Michal Masařík, Michaela Fojtů
  Nanoscale Horizons.2026;[Epub]     CrossRef
• Revolutionizing cancer treatment: ROS-induced apoptosis via nanoformulated alkaloids
  Swathi Putta, Santhosh Kumar Chinnaiyan, Ramadevi Korni, Venkata Radha Gadela
  Journal of Drug Delivery Science and Technology.2025; 104: 106556.     CrossRef
• A drug-eluting balloon catheter coated with chitosan and paclitaxel-loaded poloxamer-stabilized PLA microparticles for the effective treatment of cholangiocarcinoma
  Jin Sil Lee, Jaehee Jang, Hyeryeon Oh, Eunhye Lee, Don Haeng Lee, Panmo Son, Daekyung Sung, Won Il Choi
  Journal of Industrial and Engineering Chemistry.2025; 150: 357.     CrossRef
• Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
  Didi Yan, Xinyue Ma, Yixin Hu, Guogang Zhang, Beibei Hu, Bo Xiang, Xiaokun Cheng, Yongshuai Jing, Xi Chen
  International Journal of Nanomedicine.2025; Volume 20: 2087.     CrossRef
• Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
  Gulshan Sharma, Rohil Panwar, Sanskriti Saini, Hardeep Singh Tuli, Karan Wadhwa, Rakesh Pahwa
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(9): 11199.     CrossRef
• Integrating Nanoparticles and Herbal Extracts with Platinum-Based Chemotherapy for Enhanced Efficacy and Reduced Toxicity (A Review)
  Palash Chandra Biswas, Vikash Jakhmola, Arnab Samanta, Anandi Kapri, Arif Nur Muhammad Ansori, Rahadian Zainul
  Pharmaceutical Chemistry Journal.2025; 59(2): 159.     CrossRef
• Clinical cancer nanomedicines
  Roger M. Pallares, Roman A. Barmin, Alec Wang, Fabian Kiessling, Twan Lammers
  Journal of Controlled Release.2025; 385: 113991.     CrossRef
• Advances in paclitaxel nanoformulations: A systematic review of in vivo therapeutic efficacy and safety enhancements
  Salma Seyam, Batoul Alallam, Nurdianah Harif Fadzilah, Erazuliana Abd Kadir
  Journal of Controlled Release.2025; 385: 114036.     CrossRef
• Poly (ortho esters) (POEs) as cutting-edge biodegradable polymers for targeted cancer treatment and overcoming multidrug resistance
  Devansh Shah, Sankha Bhattacharya
  Biomedical Materials.2025; 20(4): 042004.     CrossRef
• Paclitaxel-based strategy as first-line therapy for advanced breast cancer: a model-based economic evaluation for China
  Ji-Sheng Chen, Jia Hu, Meng-Ting Li
  Future Oncology.2025; 21(23): 3005.     CrossRef
• Nanocarrier-based insulin delivery: A leap towards a needle-free future
  Saranya Balasubramaniyam, Thirumalaikumaran Rathinam, Mohanakrishnan Srinivasan, Sowmiya Jayarani
  Nano TransMed.2025; 4: 100093.     CrossRef
• Nanotechnology-enhanced phytomedicines: Innovations and applications in cancer therapy
  Rajesh Kumar, Seetha Harilal, Swati Arora, Swati Mohanty, Sumit Sheoran, Jyoti Sangwan, Divya Kanojiya, Ankita Acharya, Trideep Saikla
  International Immunopharmacology.2025; 166: 115537.     CrossRef
• Smart pH-Responsive polymers in biomedical Applications: Nanoparticles, hydrogels, and emerging hybrid platforms
  Giuseppe Nunziata, Domenico Pollonio, Elisa Lacroce, Filippo Rossi
  Materials Today Chemistry.2025; 49: 103063.     CrossRef
• Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer
  Hyehyun Jeong, Changhoon Yoo, Ilhwan Kim, Jung Hun Kang, Jae Ho Jeong, Kwonoh Park, Sang-Bo Oh, Inkeun Park, Sun Jin Sym, Jaekyung Cheon, Hyewon Ryu, Jun Eul Hwang, Ji Sung Lee, Baek-Yeol Ryoo, Kyu-pyo Kim
  JAMA Network Open.2025; 8(10): e2534560.     CrossRef
• Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery
  Yeongbeom Kim, Jaewoo Kwak, Minyeong Lim, Su Yeon Lim, Sehyun Chae, Suk-Jin Ha, Young-Wook Won, Hyun-Ouk Kim, Kwang Suk Lim
  Pharmaceutics.2025; 17(10): 1354.     CrossRef
• From Conventional to Next-Generation Strategies: Recent Advances in Polymeric Micelle Preparation for Drug Delivery
  Suhyeon Cho, Morteza Rasoulianboroujeni, Rae Hyung Kang, Glen S. Kwon
  Pharmaceutics.2025; 17(10): 1360.     CrossRef
• Navigating Cancer Treatment: A Journey from 2D to 3D Cancer Models and Nanoscale Therapies
  Navneet Kaur, Mary Jean Savitsky, Annie Scutte, Roshani Mehta, Narjes Dridi, Taiwo Sogbesan, Alexyss Savannah, Damian Lopez, Dazhi Yang, Jamel Ali
  ACS Pharmacology & Translational Science.2025; 8(11): 3773.     CrossRef
• Beyond nanomicelles and hydrogels: exploring micelle-containing hydrogels as cutting-edge drug delivery system for effective breast cancer treatment
  Ananya Bishnoi, Gunjan Vasant Bonde
  International Journal of Pharmaceutics.2025; 686: 126307.     CrossRef
• Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma
  Yu‐Qing Cao, Meng Song, Bing‐jie Xue, Fei‐Yu Wang, Xiang‐Ming Huang, Jie Cao, Ai‐Guo Cao, Xin‐En Huang
  Precision Medical Sciences.2025;[Epub]     CrossRef
• Label-Free Analysis Reveals In Vivo Premature Drug Release Governed by Diffusion from Polymeric Micelles
  Jiayi Yao, Jiefang Sun, Xinyi Wang, Haoran Wang, Yuqi Liu, Mingyang Zhao, Xiangjun Meng, Jingkai Gu
  Nano Letters.2025; 25(52): 18132.     CrossRef
• Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy
  Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, Roxana Noemí Peroni, Marlus Chorilli
  Current Medicinal Chemistry.2024; 31(6): 726.     CrossRef
• Innovative strategies for effective paclitaxel delivery: Recent developments and prospects
  Sławomir Wileński, Agnieszka Koper, Paulina Śledzińska, Marek Bebyn, Krzysztof Koper
  Journal of Oncology Pharmacy Practice.2024; 30(2): 367.     CrossRef
• Effect of zwitterionic sulfobetaine incorporation on blood behaviours, phagocytosis, and in vivo biodistribution of pH-responsive micelles with positive charges
  Chengwei Wang, Hao Liu, Hu Lin, Rui Zhong, Hao Li, Jiaxin Liu, Xianglin Luo, Meng Tian
  Journal of Materials Chemistry B.2024; 12(6): 1652.     CrossRef
• Reexamining in vivo fate of paclitaxel-loaded polymeric micelles
  Shiqi Lin, Yifei Yu, Ercan Wu, Tianhao Ding, Yuxiu Chu, Feng Pan, Yang Yang, Changyou Zhan
  Nano Today.2024; 56: 102255.     CrossRef
• Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials
  Ana Serras, Célia Faustino, Lídia Pinheiro
  Pharmaceutics.2024; 16(8): 1047.     CrossRef
• Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy
  Giuseppe Longobardi, Thomas Lee Moore, Claudia Conte, Francesca Ungaro, Ronit Satchi‐Fainaro, Fabiana Quaglia
  WIREs Nanomedicine and Nanobiotechnology.2024;[Epub]     CrossRef
• Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
  Jia-xin Qiao, Dong-yan Guo, Huan Tian, Zhan-peng Wang, Qiang-qiang Fan, Yuan Tian, Jing Sun, Xiao-fei Zhang, Jun-bo Zou, Jiang-xue Cheng, Fei Luan, Bing-tao Zhai
  Materials Today Bio.2024; 29: 101358.     CrossRef
• Nanotechnology in cancer therapeutics, diagnosis, and management
  Disha Hazarika, Sumit Sarma, Priyanka Shankarishan
  BioTechnologia.2024; 105(3): 287.     CrossRef
• Microwave‐Assisted Synthesis of Porous Biomolecule‐Incorporated Metal‐Organic Frameworks as Efficient Nanocarriers for Anti‐Cancer Drugs
  Trang Thi Thu Nguyen, Bao Quang Gia Le, Vy Tran Hanh Nguyen, Jae‐Hyoung Lee, Ngoc Xuan Dat Mai, Linh Ho Thuy Nguyen, Tan Le Hoang Doan
  ChemistrySelect.2023;[Epub]     CrossRef
• Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances
  Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu, Mahitosh Mandal
  WIREs Nanomedicine and Nanobiotechnology.2023;[Epub]     CrossRef
• Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives
  Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi, Ajaikumar B. Kunnumakkara
  Cancer Letters.2023; 556: 216066.     CrossRef
• Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs
  Weixia Xu, Shengmin Yang, Linwei Lu, Qianzhu Xu, Sunyi Wu, Jianfen Zhou, Jiashen Lu, Xingyan Fan, Nana Meng, Yuan Ding, Xudong Zheng, Weiyue Lu
  Journal of Controlled Release.2023; 354: 538.     CrossRef
• Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
  Ranga Dissanayake, Rheal Towner, Marya Ahmed
  Cancers.2023; 15(11): 2906.     CrossRef
• Efficacy and Safety of Nanopaclitaxel Formulation for Cancer Treatment: Evidence From Randomized Clinical Trials
  Xiangmin Deng, Xiaoqin Huang, Xiaoyan Dong, Genxiang Mao, Wenmin Xing
  Nanomedicine.2023; 18(10): 833.     CrossRef
• Combination Therapy as a Promising Way to Fight Oral Cancer
  João P. N. Silva, Bárbara Pinto, Luís Monteiro, Patrícia M. A. Silva, Hassan Bousbaa
  Pharmaceutics.2023; 15(6): 1653.     CrossRef
• Nano delivery system for paclitaxel: Recent advances in cancer theranostics
  Na Ying, Sisi Liu, Mengmeng Zhang, Jing Cheng, Linghuan Luo, Jiayi Jiang, Gaofan Shi, Shu Wu, Jun Ji, Haoyuan Su, Hongzhi Pan, Dongdong Zeng
  Colloids and Surfaces B: Biointerfaces.2023; 228: 113419.     CrossRef
• Current Perspectives on Paclitaxel: Focus on Its Production, Delivery and Combination Therapy
  Yibin Liu, Fenglan Zhao, Qibao Wang, Qingjie Zhao, Guige Hou, Qingguo Meng
  Mini-Reviews in Medicinal Chemistry.2023; 23(18): 1780.     CrossRef
• Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review
  Sheng Sun, Ye-hui Wang, Xiang Gao, He-yong Wang, Lu Zhang, Na Wang, Chun-mei Li, Shao-quan Xiong
  Frontiers in Bioengineering and Biotechnology.2023;[Epub]     CrossRef
• Paclitaxel prodrug-encapsulated polypeptide micelles with redox/pH dual responsiveness for cancer chemotherapy
  Jinyu Liu, Yanhao Zhang, Chao Liu, Yuhao Jiang, Zihao Wang, Xinsong Li
  International Journal of Pharmaceutics.2023; 645: 123398.     CrossRef
• Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021–2023)
  Zongheng Wang, Miaomiao Xiao, Fangliang Guo, Yue Yan, Hong Tian, Qianshi Zhang, Shuangyi Ren, Liqun Yang
  Frontiers in Bioengineering and Biotechnology.2023;[Epub]     CrossRef
• Comparison of triblock copolymeric micelles based on α- and ε-poly(L-lysine): a Cornelian choice
  Franck Marquet, Viorica Patrulea, Gerrit Borchard
  Polymer Journal.2022; 54(2): 199.     CrossRef
• Current understandings and clinical translation of nanomedicines for breast cancer therapy
  Yike Jiang, Ziyi Jiang, Mingzhe Wang, Lan Ma
  Advanced Drug Delivery Reviews.2022; 180: 114034.     CrossRef
• Poly(ϵ-Caprolactone)-Methoxypolyethylene Glycol (PCL-MPEG)-Based Micelles for Drug-Delivery: The Effect of PCL Chain Length on Blood Components, Phagocytosis, and Biodistribution
  Zemin Hou, Wencheng Zhou, Xi Guo, Rui Zhong, Ao Wang, Jiehua Li, Ying Cen, Chao You, Hong Tan, Meng Tian
  International Journal of Nanomedicine.2022; Volume 17: 1613.     CrossRef
• Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy
  Prashant Pandey, Dilip Kumar Arya, Mohan Kumar Ramar, Kumarappan Chidambaram, P.S. Rajinikanth
  Drug Discovery Today.2022; 27(9): 2526.     CrossRef
• Biophysical Characterization of Interactions between Serum Albumin and Block Copolymer Micelles
  Catherine F. Dial, Richard A. Gemeinhart
  ACS Biomaterials Science & Engineering.2022; 8(7): 2899.     CrossRef
• Micelles in Cancer Therapy: An Update on Preclinical and Clinical Status
  Rabia Aqeel, Nidhi Srivastava, Poonam Kushwaha
  Recent Patents on Nanotechnology.2022; 16(4): 283.     CrossRef
• Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
  Juanjuan Yang, Xiaojin Wang, Bingshun Wang, Kinam Park, Karen Wooley, Shiyi Zhang
  Advanced Drug Delivery Reviews.2022; 190: 114525.     CrossRef
• In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel
  Robin Vinck, Laetitia Anvi Nguyen, Mathilde Munier, Lucie Caramelle, Diana Karpman, Julien Barbier, Alain Pruvost, Jean-Christophe Cintrat, Daniel Gillet
  International Journal of Molecular Sciences.2022; 23(23): 14611.     CrossRef
• Clinical Translation of Self‐Assembled Cancer Nanomedicines
  Peng Mi, Kanjiro Miyata, Kazunori Kataoka, Horacio Cabral
  Advanced Therapeutics.2021;[Epub]     CrossRef
• From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
  Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza, Laura Peña
  Frontiers in Veterinary Science.2021;[Epub]     CrossRef
• Advanced Biotechnologies: Collections of Plant Cell Cultures As a Basis for Development and Production of Medicinal Preparations
  E. V. Popova, A. V. Nosov, M. V. Titova, D. V. Kochkin, A. A. Fomenkov, I. E. Kulichenko, A. M. Nosov
  Russian Journal of Plant Physiology.2021; 68(3): 385.     CrossRef
• Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
  Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Pan Shu, Joseph P. Burnett, Nathan Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao, Duxin Sun
  Biomaterials.2021; 275: 120910.     CrossRef
• Breast cancer: Muscarinic receptors as new targets for tumor therapy
  Alejandro Español, Agustina Salem, Yamila Sanchez, María Elena Sales
  World Journal of Clinical Oncology.2021; 12(6): 404.     CrossRef
• Direct Comparison of Analogous Amphiphilic Gradient and Block Polyoxazolines
  Lenka Loukotová, Pavel Švec, Ondřej Groborz, Tomáš Heizer, Hynek Beneš, Helena Raabová, Tereza Bělinová, Vít Herynek, Martin Hrubý
  Macromolecules.2021; 54(17): 8182.     CrossRef
• Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
  Muhammad Nadeem Hafeez, Christian Celia, Vilma Petrikaite
  Processes.2021; 9(9): 1527.     CrossRef
• Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature
  Kah Min Yap, Mahendran Sekar, Shivkanya Fuloria, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Vetriselvan Subramaniyan, Chandrakant Kokare, Pei Teng Lum, M Yasmin Begum, Shankar Mani, Dhanalekshmi Unnikrishnan Meenakshi, Kathiresan V Sathasiva
  International Journal of Nanomedicine.2021; Volume 16: 7891.     CrossRef
• Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
  Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim, Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee
  Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
• Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy
  Chengyuan Dong, Quan Zhou, Jiajia Xiang, Fusheng Liu, Zhuxian Zhou, Youqing Shen
  Journal of Controlled Release.2020; 321: 529.     CrossRef
• Clinical applications of nanomedicine in cancer therapy
  Mohammad Norouzi, Mehrnaz Amerian, Mahshid Amerian, Fatemeh Atyabi
  Drug Discovery Today.2020; 25(1): 107.     CrossRef

• Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis

  
  Pi-Ling Chou, Ya-Ping Huang, Meng-Hsuan Cheng, Kun-Ming Rau, Yi-Ping Fang
  International Journal of Nanomedicine.2020; Volume 15: 1731.     CrossRef
• Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review
  Adam S. Komorowski, Helen J. MacKay, Rossanna C. Pezo
  Cancer Medicine.2020; 9(14): 5035.     CrossRef
• Nanotechnology for angiogenesis: opportunities and challenges
  Saeid Kargozar, Francesco Baino, Sepideh Hamzehlou, Michael R. Hamblin, Masoud Mozafari
  Chemical Society Reviews.2020; 49(14): 5008.     CrossRef
• Furry nanoparticles: synthesis and characterization of nanoemulsion-mediated core crosslinked nanoparticles and their robust stability in vivo
  Rena Tanaka, Koichi Arai, Jun Matsuno, Miyo Soejima, Ji Ha Lee, Rintaro Takahashi, Kazuo Sakurai, Shota Fujii
  Polymer Chemistry.2020; 11(27): 4408.     CrossRef
• Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
  Duhyeong Hwang, Jacob D. Ramsey, Alexander V. Kabanov
  Advanced Drug Delivery Reviews.2020; 156: 80.     CrossRef
• What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
  Duxin Sun, Simon Zhou, Wei Gao
  ACS Nano.2020; 14(10): 12281.     CrossRef
• Synthesis of PCL–PEG–PCL Triblock Copolymer via Organocatalytic Ring-Opening Polymerization and Its Application as an Injectable Hydrogel—An Interdisciplinary Learning Trial
  Kaiting Wu, Lin Yu, Jiandong Ding
  Journal of Chemical Education.2020; 97(11): 4158.     CrossRef

• Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use

  
  Madhusmita Dhupal, Devasish Chowdhury
  International Journal of Nanomedicine.2020; Volume 15: 9125.     CrossRef
• A Compressive Review about Taxol®: History and Future Challenges
  Julia Gallego-Jara, Gema Lozano-Terol, Rosa Alba Sola-Martínez, Manuel Cánovas-Díaz, Teresa de Diego Puente
  Molecules.2020; 25(24): 5986.     CrossRef
• Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
  Ruben AG van Eerden, Ron HJ Mathijssen, Stijn LW Koolen
  International Journal of Nanomedicine.2020; Volume 15: 8151.     CrossRef
• Basic principles of drug delivery systems – the case of paclitaxel
  S. Ezrahi, A. Aserin, N. Garti
  Advances in Colloid and Interface Science.2019; 263: 95.     CrossRef
• Biomolecules Turn Self-Assembling Amphiphilic Block Co-polymer Platforms Into Biomimetic Interfaces
  Saziye Yorulmaz Avsar, Myrto Kyropoulou, Stefano Di Leone, Cora-Ann Schoenenberger, Wolfgang P. Meier, Cornelia G. Palivan
  Frontiers in Chemistry.2019;[Epub]     CrossRef
• Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy
  R. Ganugula, M. Deng, M. Arora, H.-L. Pan, M. N. V. Ravi Kumar
  ACS Chemical Neuroscience.2019; 10(3): 1801.     CrossRef
• PEGylation of Ginsenoside Rg3-Entrapped Bovine Serum Albumin Nanoparticles: Preparation, Characterization, and In Vitro Biological Studies
  Lijun Zhang, Junfeng Hui, Pei Ma, Yu Mi, Daidi Fan, Chenhui Zhu, Lei Chi, Yanan Dong
  Journal of Nanomaterials.2019; 2019: 1.     CrossRef
• Prevention of paclitaxel-induced neuropathy by formulation approach
  Xiaowei Zang, Jong Bong Lee, Kiran Deshpande, Olga B. Garbuzenko, Tamara Minko, Leonid Kagan
  Journal of Controlled Release.2019; 303: 109.     CrossRef
• Current status of nanomedicine in the chemotherapy of breast cancer
  A. I. Fraguas-Sánchez, C. Martín-Sabroso, A. Fernández-Carballido, A. I. Torres-Suárez
  Cancer Chemotherapy and Pharmacology.2019; 84(4): 689.     CrossRef
• A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
  Bhumsuk Keam, Keun-Wook Lee, Se-Hoon Lee, Jin-Soo Kim, Jin Ho Kim, Hong-Gyun Wu, Keun-Yong Eom, Suzy Kim, Soon-Hyun Ahn, Eun-Jae Chung, Seong Keun Kwon, Woo-Jin Jeong, Young Ho Jung, Ji-Won Kim, Dae Seog Heo
  The Oncologist.2019; 24(6): 751.     CrossRef
• Advances in thermosensitive polymer-grafted platforms for biomedical applications
  Phung Ngan Le, Chan Khon Huynh, Ngoc Quyen Tran
  Materials Science and Engineering: C.2018; 92: 1016.     CrossRef
• Supramolecular polymeric chemotherapy based on cucurbit[7]uril-PEG copolymer
  Hao Chen, Yueyue Chen, Han Wu, Jiang-Fei Xu, Zhiwei Sun, Xi Zhang
  Biomaterials.2018; 178: 697.     CrossRef
• pH/NIR-Responsive Polypyrrole-Functionalized Fibrous Localized Drug-Delivery Platform for Synergistic Cancer Therapy
  Arjun Prasad Tiwari, Tae In Hwang, Jung-Mi Oh, Bikendra Maharjan, Sungkun Chun, Beom Su Kim, Mahesh Kumar Joshi, Chan Hee Park, Cheol Sang Kim
  ACS Applied Materials & Interfaces.2018; 10(24): 20256.     CrossRef
• The Blood Clearance Kinetics and Pathway of Polymeric Micelles in Cancer Drug Delivery
  Xuanrong Sun, Guowei Wang, Hao Zhang, Shiqi Hu, Xin Liu, Jianbin Tang, Youqing Shen
  ACS Nano.2018; 12(6): 6179.     CrossRef
• Different Nanoformulations Alter the Tissue Distribution of Paclitaxel, Which Aligns with Reported Distinct Efficacy and Safety Profiles
  Feng Li, Huixia Zhang, Miao He, Jinhui Liao, Nianhang Chen, Yan Li, Simon Zhou, Maria Palmisano, Alex Yu, Manjunath P. Pai, Hebao Yuan, Duxin Sun
  Molecular Pharmaceutics.2018; 15(10): 4505.     CrossRef
• Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery
  Longfa Kou, Rui Sun, Yangzom D. Bhutia, Qing Yao, Ruijie Chen
  Expert Opinion on Drug Delivery.2018; 15(9): 869.     CrossRef
• The battle of “nano” paclitaxel
  Alexandros Marios Sofias, Michael Dunne, Gert Storm, Christine Allen
  Advanced Drug Delivery Reviews.2017;[Epub]     CrossRef
• Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic
  Loujin Houdaihed, James C. Evans, Christine Allen
  Molecular Pharmaceutics.2017; 14(8): 2503.     CrossRef
• PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
  Philip Grossen, Dominik Witzigmann, Sandro Sieber, Jörg Huwyler
  Journal of Controlled Release.2017; 260: 46.     CrossRef
• Effect of Thermoresponsive Poly(L-lactic acid)–poly(ethylene glycol) Gel Injection on Left Ventricular Remodeling in a Rat Myocardial Infarction Model
  Shota Somekawa, Atsushi Mahara, Kazunari Masutani, Yoshiharu Kimura, Hiroshi Urakawa, Tetsuji Yamaoka
  Tissue Engineering and Regenerative Medicine.2017; 14(5): 507.     CrossRef
• A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer
  Xin-shuai Wang, De-jiu Kong, Tzu-yin Lin, Xiao-cen Li, Yoshihiro Izumiya, Xue-zhen Ding, Li Zhang, Xiao-chen Hu, Jun-qiang Yang, She-gan Gao, Kit S Lam, Yuan-pei Li
  Acta Pharmacologica Sinica.2017; 38(6): 931.     CrossRef

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease. The prognosis is poor in most cases with rapid progression despite administering chemotherapy. A 67-year-old man complained of skin rashes on his back and this spread to the trunk, face, arms and thighs, and he was initially diagnosed with cutaneous lupus erythematosus according to the skin biopsy. The skin rashes then became aggravated on a trial of low dose methylprednisolone for 3 months. Repeated skin biopsy revealed a diffuse infiltration of lymphoid cells with medium sized nuclei, positive for CD4 and CD56, negative for Epstein-Barr virus (EBV), indicating a diagnosis of BPDCN. Further workups confirmed stage IVA BPDCN involving the skin, multiple lymph nodes, the peripheral blood and the bone marrow. He was treated with six cycles of combination chemotherapy consisting of ifosphamide, methotrexate, etoposide, prednisolone and L-asparaginase, and he achieved a partial response. Herein we report on a rare case of BPDCN that was initially misinterpreted as cutaneous lupus erythematosus.

Citations

Citations to this article as recorded by  

• Blastic plasmacytoid dendritic cell neoplasm misdiagnosed and treated as acute febrile neutrophilic dermatosis
  Yuqing Song, Yingying Dong, Lin Gong
  Indian Journal of Dermatology, Venereology and Leprology.2025; 0: 1.     CrossRef
• Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
  Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, Claudia Paganini, Elena Campione, Marco Galluzzo, Luca Bianchi
  International Journal of Molecular Sciences.2024; 25(13): 7099.     CrossRef
• Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm
  Michael Haddadin, Justin Taylor
  Hematology/Oncology Clinics of North America.2020; 34(3): 539.     CrossRef
• Dendritic Cell Leukemia: a Review
  Nikolaos J. Tsagarakis, Georgios Paterakis
  Current Oncology Reports.2020;[Epub]     CrossRef
• Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review
  Marie Jeong-Min Kim, Ahmed Nasr, Bilaal Kabir, Joseph de Nanassy, Ken Tang, Danielle Menzies-Toman, Donna Johnston, Dina El Demellawy
  Journal of Pediatric Hematology/Oncology.2017; 39(7): 528.     CrossRef
• Simultaneous deletion of 3′ETV6 and 5′EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review
  Zhenya Tang, Guilin Tang, Sa A. Wang, Xinyan Lu, Ken H. Young, Carlos E. Bueso-Ramos, Yesid Alvarado, L. Jeffrey Medeiros, Joseph D. Khoury
  Molecular Cytogenetics.2016;[Epub]     CrossRef
• NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)
  M. A. Frenkel’, O. Yu. Baranova, Alina Sergeevna Antipova, N. A. Kupryshina, N. N. Tupitsyn
  Clinical Oncohematology.2016; 9(2): 208.     CrossRef
• Blastic plasmacytoid dendritic neoplasm (BPDN) or BPDN-like lesion presenting after influenza vaccination and resolving with topical high potency steroid
  Jonathan Yao, Joanna Dong, James Strauchen, Rajendra Singh
  JAAD Case Reports.2015; 1(4): 203.     CrossRef
• Lupus mimickers
  Omar-Javier Calixto, Juan-Sebastian Franco, Juan-Manuel Anaya
  Autoimmunity Reviews.2014; 13(8): 865.     CrossRef
• Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
  Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Taiga Nishihori, Rami A. Mahfouz, Mehdi Hamadani
  Biology of Blood and Marrow Transplantation.2013; 19(7): 1006.     CrossRef
• Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature
  Wanzhuo Xie, Yanmin Zhao, Ling Cao, Weijia Huang, Yanli Wang, He Huang
  Medical Oncology.2012; 29(4): 2417.     CrossRef
• Cutaneous lupus erythematosus: a great imitator
  Ashok Kumar Khare
  Expert Review of Dermatology.2011; 6(6): 555.     CrossRef

Plasmablastic lymphoma (PBL) of the oral cavity is an acquired immunodeficiency syndrome-related lymphoma. The immunophenotype of this disease is associated with poor expression of B-cell markers but a positive reactivity for plasma cell markers. PBL is highly aggressive and responds poorly to treatment. Although originally described in the oral cavity, this disease can occur in other body niches. Here, we describe a very rare case of PBL in the anal canal of a 40-year-old woman with human immunodeficiency virus infection. The malignant cells were positive for Epstein-Barr virus and human herpes virus 8.

Citations

Citations to this article as recorded by  

• Plasmablastic Lymphoma of the Anorectal Region in a Human Immunodeficiency Virus (HIV)-Positive Patient: Integrating Radiologic Findings
  Erwin J Narváez-García, Aldo M Pacheco-Carrillo, Flor E Ortiz-Villeda, Matías Salinas-Chapa, Guillermo Elizondo-Riojas, Rodolfo Franco-Marquez
  Cureus.2025;[Epub]     CrossRef
• Anal lymphoma: a tumor with insufficient attention
  Xibo Liu, Hongliang Chen
  Discover Oncology.2023;[Epub]     CrossRef
• A Case of Anal Malignant Lymphoma in which Excisional Biopsy was Useful for Confirming the Diagnosis
  Shun AKIYAMA, Mitsuru YOKOTA, Akitaka MORIKAWA, Michio OKABE, Hirohisa KITAGAWA, Kazuyuki KAWAMOTO
  Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2023; 84(4): 620.     CrossRef
• Anorectal pathology in the HIV population: a guide for radiologists
  Derek Vos, Margaret Wang, Sita Ramaiya, Elias G. Kikano, Sree H. Tirumani, Daniel A. Smith
  Abdominal Radiology.2022; 47(5): 1762.     CrossRef
• Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient
  Yuka Fukuo, Tomoyoshi Shibuya, Karin Ashizawa, Kentaro Ito, Michio Saeki, Hirofumi Fukushima, Masahito Takahashi, Kei Nomura, Koki Okahara, Keiichi Haga, Yoichi Akazawa, Osamu Nomura, Kanako Ogura, Hironao Okubo, Akihito Nagahara
  Internal Medicine.2021; 60(18): 2947.     CrossRef
• Fistulizing Epstein-Barr virus-positive plasmablastic lymphoma in an HIV-positive man
  J. Rangel, R. Novoa, C. Morrison, D. Frank, C. Kovarik
  British Journal of Dermatology.2016; 174(2): 398.     CrossRef
• Linfoma plasmablástico anal. Reporte de dos casos
  Cristina Grijalva-Santana, David San Marcos-Romero, Billy Jiménez-Bobadilla, Saulo Mendoza-Ramírez, Milly Diorey Reyes-Hansen, Carlos Cosme-Reyes
  Cirujano General.2016; 38(2): 78.     CrossRef
• Plasmoblastic Lymphoma as Cause of Perianal Fistula
  Firoozeh Isfahani, Surabhi Amar, Harikrishna Dave, Daniel Gridley
  Journal of the International Association of Providers of AIDS Care (JIAPAC).2015; 14(1): 17.     CrossRef
• A Case of Oral Plasmablastic Lymphoma and Review of Current Trends in Oral Manifestations Associated With Human Immunodeficiency Virus Infection
  Nicholas Medel, Aya Hamao-Sakamoto
  Journal of Oral and Maxillofacial Surgery.2014; 72(9): 1729.     CrossRef
• Plasmablastic Lymphoma of the Anal Canal in an HIV-Infected Patient
  Agnaldo José Lopes
  American Journal of Case Reports.2014; 15: 543.     CrossRef
• Manifestations of gastrointestinal plasmablastic lymphoma: A case series with literature review
  Lynette Luria
  World Journal of Gastroenterology.2014; 20(33): 11894.     CrossRef
• A Case of Anal Malignant Lymphoma Coexistent with Adult T-cell Leukemia
  Katsuhisa Ohashi, Akinori Sasaki, Yoshihiro Matsuo, Katsuhide Ohashi
  Nippon Daicho Komonbyo Gakkai Zasshi.2013; 66(4): 269.     CrossRef
• Extraoral plasmablastic lymphoma with intravascular component and MYC translocation
  Jennifer Chapman-Fredricks, Naomi Montague, Ikechukwu Akunyili, Offiong Ikpatt
  Annals of Diagnostic Pathology.2012; 16(1): 48.     CrossRef
• A Case of Anal Malignant Lymphoma
  Satoru Umegae, Koichi Matsumoto, Tatsushi Kitagawa, Midori Noji, Takayuki Yamamoto, Masaaki Ishii, Kiyoshi Narita, Takahiro Torii, Tomonori Himan, Manabu Yamazaki
  Nippon Daicho Komonbyo Gakkai Zasshi.2011; 64(5): 332.     CrossRef
• Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection
  Rocio Plaza, Angel Ponferrada, Dulce M. Benito, Noelia Arevalo, Maria Angeles Foncillas, Maria Luisa de Fuenmayor, Mercedes Aldeguer
  Journal of Crohn's and Colitis.2011; 5(6): 628.     CrossRef
• Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case report
  Mayur Brahmania, Thomas Sylwesterowic, Heather Leitch
  Journal of Medical Case Reports.2011;[Epub]     CrossRef
• Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature
  M Corti, M F Villafañe, A Bistmans, A Campitelli, M Narbaitz, P Baré
  International Journal of STD & AIDS.2011; 22(12): 759.     CrossRef
• Assessment of Plasmablastic Lymphoma by F-18 FDG PET/CT
  Thomas Cazaentre, Laurence Sanhes, Guillaume Laurent, Keltoum Costa, Xavier Vallantin, Dominique Pascal-Ortiz
  Clinical Nuclear Medicine.2010; 35(11): 882.     CrossRef